KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 204 filers reported holding KURA ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,675,643 | -54.8% | 296,184 | -50.3% | 0.01% | -18.8% |
| Q3 2022 | $8,135,770 | -39.1% | 595,574 | -18.3% | 0.02% | -36.0% |
| Q2 2022 | $13,364,183 | +11.8% | 729,098 | -1.9% | 0.02% | +47.1% |
| Q1 2022 | $11,951,971 | +170.3% | 743,280 | +135.3% | 0.02% | +54.5% |
| Q4 2021 | $4,422,000 | +38.7% | 315,852 | +85.5% | 0.01% | +22.2% |
| Q3 2021 | $3,188,000 | -53.4% | 170,226 | -48.1% | 0.01% | -10.0% |
| Q2 2021 | $6,838,000 | +37.1% | 327,914 | +85.9% | 0.01% | -33.3% |
| Q1 2021 | $4,987,000 | -11.8% | 176,411 | +1.9% | 0.02% | -16.7% |
| Q4 2020 | $5,655,000 | -15.0% | 173,141 | -20.3% | 0.02% | -25.0% |
| Q3 2020 | $6,654,000 | -35.2% | 217,163 | -65.5% | 0.02% | +20.0% |
| Q2 2020 | $10,264,000 | +58.2% | 629,742 | -3.4% | 0.02% | +25.0% |
| Q1 2020 | $6,488,000 | – | 652,110 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,807,982 | $59,049,000 | 6.41% |
| ACUTA CAPITAL PARTNERS, LLC | 637,500 | $20,821,000 | 5.67% |
| Asymmetry Capital Management, L.P. | 346,518 | $11,317,000 | 5.16% |
| Affinity Asset Advisors, LLC | 260,000 | $8,492,000 | 4.50% |
| EcoR1 Capital, LLC | 1,773,037 | $57,907,000 | 3.11% |
| VR Adviser, LLC | 575,000 | $18,780,000 | 2.76% |
| COMMODORE CAPITAL LP | 133,503 | $4,360,000 | 2.37% |
| Ghost Tree Capital, LLC | 325,000 | $10,615,000 | 2.36% |
| Avoro Capital Advisors LLC | 4,000,000 | $130,640,000 | 2.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 90,000 | $2,939,000 | 1.71% |